Ultrasound technology developed at the Norwegian University of Science and Technology (NTNU) makes it possible to monitor cerebral blood flow in newborn babies, helping prevent brain damage in premature and sick infants who require surgery.
Pfizer and Valneva say second Lyme booster led to ‘strong’ responses, target 2026 FDA submission
Pfizer and Valneva said patients demonstrated “strong immune responses” after receiving a second booster dose of their experimental Lyme disease vaccine, supporting the case for
September 4, 2024